1. • Keus S. H. J. MM, Graziano M., Paltamaa J., Pelosin E., Domingos J., Susanne B., Ramaswamy B., Prins J., Struiksma C., Rochester L., Nieuwboer A., Bloem B., On behalf of the Guideline Development Group. European physiotherapy guideline for Parkinson’s disease. The Netherlands: KNGF/ParkinsonNet; 2014. This clinical practice guideline was developed in Europe to guide physiotherapy practice in Parkinson’s disease and includes evidence from clinical research, physiotherapists, and people with Parkinson’s disease.
2. • Sturkenboom I, Thijssen M, Gons-van Elsacker J, Jansen I, Maasdam A, Schulten M et al. Guidelines for occupational therapy in Parkinson’s disease rehabilitation. vol 3. Nijmegen, The Netherlands/Miami (FL), USA: ParkinsonNet/NPF; 2011. This clinical practice guideline is a set of recommendations for optimal occupational therapy practice in Parkinson’s disease that was developed through the collaboration of researchers and professionals in Nijmegen, and that has been evaluated by a panel of patients and caregivers from the Dutch Parkinson’s Disease Association.
3. • Kalf J, de Swart B, Bonnier M, Hofman M, Kanters J, Kocken J et al. Guidelines for speech-language therapy in Parkinson’s disease. Nijmegen, The Netherlands/Miami, FL: ParkinsonNet/NPF; 2011. This clinical practice guideline is a set of recommendations for optimal speech-language treatment of PwP and their caregivers that was developed based on current scientific literature and professional insights, and that has been evaluated by a panel of patients and caregivers from the Dutch Parkinson Association.
4. • Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon EA, Schlossmacher M et al. Canadian guideline for Parkinson disease. Canadian Medical Association Journal. 2019;191(36):E989-E1004. https://doi.org/10.1503/cmaj.181504. This clinical practice guideline was developed in Canada based on published evidence and expert consensus and was updated with input from clinicians and PwP. The guideline covers recommendations for health care delivery for Canadians with Parkinson’s disease including recommendations for rehabilitation.
5. • National Institute for Health and Care Excellence. Non-pharmacological management of motor and non-motor symptoms. In: NICE guideline: Parkinson’s disease in adults. National Institute for Health and Care Excellence. 2017. https://www.nice.org.uk/guidance/ng71/chapter/Recommendations#non-pharmacological-management-of-motor-and-non-motor-symptoms. Accessed September 15 2020. This clinical practice guideline was developed in the UK based on best available evidence and insight from experts, people using the services, carers, and the public. The guideline covers the diagnosing and managing of Parkinson’s disease including recommendations for rehabilitation.